These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3360 related items for PubMed ID: 16536636

  • 1. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN, Chan P, Tomlinson B.
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [Abstract] [Full Text] [Related]

  • 2. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH.
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A, Divchev D, Luchtefeld M, Schieffer B.
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [Abstract] [Full Text] [Related]

  • 4. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A, Battegay E.
    Praxis (Bern 1994); 2005 Apr 13; 94(15):581-94. PubMed ID: 15884724
    [Abstract] [Full Text] [Related]

  • 5. Goals of antihypertensive therapy.
    McVeigh GE, Flack J, Grimm R.
    Drugs; 1995 Feb 13; 49(2):161-75. PubMed ID: 7729325
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 13; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    Swedish Council on Health Technology Assessment.
    ; 2008 09 13. PubMed ID: 28876740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR.
    Drugs; 2005 09 13; 65 Suppl 2():29-39. PubMed ID: 16398060
    [Abstract] [Full Text] [Related]

  • 11.
    Swedish Council on Health Technology Assessment.
    ; 2004 10 13. PubMed ID: 28876790
    [Abstract] [Full Text] [Related]

  • 12. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2015 Feb 13; 33(2):195-211. PubMed ID: 25485720
    [Abstract] [Full Text] [Related]

  • 13. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C, Parati G, Zanchetti A.
    J Hypertens; 2018 Aug 13; 36(8):1637-1647. PubMed ID: 29847487
    [Abstract] [Full Text] [Related]

  • 14. Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 years.
    Gradman AH.
    Drugs Aging; 2009 Aug 13; 26(9):751-67. PubMed ID: 19728749
    [Abstract] [Full Text] [Related]

  • 15. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA.
    J Hypertens Suppl; 1997 Dec 13; 15(6):S31-6. PubMed ID: 9493125
    [Abstract] [Full Text] [Related]

  • 16. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP, Valsartan In Diastolic Dysfunction (VALIDD) Investigators.
    Lancet; 2007 Jun 23; 369(9579):2079-87. PubMed ID: 17586303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACE inhibitors. Differential use in elderly patients with hypertension.
    Israili ZH, Hall WD.
    Drugs Aging; 1995 Nov 23; 7(5):355-71. PubMed ID: 8573991
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 23; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 20. Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.
    Volpe M, Tocci G.
    Drugs Aging; 2013 Dec 23; 30(12):987-98. PubMed ID: 24170236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 168.